Indication
Relapsing Multiple Sclerosis
3 clinical trials
4 products
Clinical trial
An Open-Label, Multicenter, Biomarker Study to Explore the Mechanism of Action of Ocrelizumab and B-Cell Biology in Patients With Relapsing Multiple Sclerosis or Primary Progressive Multiple SclerosisStatus: Completed, Estimated PCD: 2023-04-11
Product
AntihistamineProduct
OcrelizumabProduct
MethyloprednisoloneClinical trial
A Prospective, Observational Study Evaluating Persistence on Treatment, Safety, Tolerability, and Effectiveness of Diroximel Fumarate in the Real-World Setting (EXPERIENCE-US Study)Status: Terminated, Estimated PCD: 2023-04-14
Product
Diroximel FumarateClinical trial
A Prospective, Observational Study Evaluating Persistence on Treatment, Safety, Tolerability, and Effectiveness of Diroximel Fumarate in the Real-World Setting (EXPERIENCE-CA+IL Study)Status: Terminated, Estimated PCD: 2023-04-14